首页|期刊导航|中华医学杂志(英文版)|Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study

Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort studyOACSCDCSTPCD

Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study

Yong-Qin Zeng;Jiang Xiao;Cui-Lin Li;Yu Wang;Ling Zhang;Xiao-Li Pang;Di Wang;Juan Du;Hong-Xin Zhao

Department of Infection,Beijing Ditan Hospital,Peking University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaDepartment of Infection,Beijing Ditan Hospital,Peking University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaClinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,ChinaDepartment of Infection,Beijing Ditan Hospital,Peking University,Beijing 100015,China

Human immunodeficiency virus(HIV)Antiretroviral therapy-naiveBone mineral densityBody mass index

Human immunodeficiency virus(HIV)Antiretroviral therapy-naiveBone mineral densityBody mass index

《中华医学杂志(英文版)》 2020 (24)

2940-2946,7

This study was supported by the grants from the National Key Project"Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis:Popularization and application of diagnosis and treatment of Belt and Road HIV/AIDS with Traditional Chinese Medicine"(No.2018ZX10101001-005-001)the National Key Project"The Development of New Pharmaceuticals:the Con-struction of Platform for Clinical Evaluation of New Antiretroviral Therapy-Clinical trial phase Ⅰ-Ⅳ"(No.2017ZX09304027-001-010)the Thirteen-fifth Key Project "The Study of Construction of Representative Areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District,Beijing"(No.2018ZX10715-005)the National Natural Science Foundation "The Study for Delay and Persistent Poor Immune Reconstitution in HIV/AIDS Patients"(No.81672000)Project from Beijing Municipal Committee of Science & Technology "The study of HIV/HBV co-infection"(No.D161100000416004)Project for Capital Characteristics "The study for blood concentration of efavirenz influenced by rifampin in HIV/TB co-infected patient"(No.Z171100001017053)The Key Project from Beijing Hospital Authority(No.DFL20191802)Major Project of Beijing Municipal Science and Technology Committee(No.D161100000416003).

10.1097/CM9.0000000000001317

评论

您当前未登录!去登录点击加载更多...